Five-year clinical outcome and immune biomarkers of durable response from the MM1636 trial on IDO/PD-L1 vaccination and PD-1 blockade in first line metastatic melanoma
- Sidsel Pedersen
- Mikkel Byrdal
- Evelina Martinenaite
- Cathrine Lund Lorentzen
- Julie Westerlin Kjeldsen
- Steffen Ullitz Thorsen
- Anders Kverneland
- Mai-Britt Zocca
- Mads Hald Andersen
- Inge Marie Svane
2025-12-14